0,875  0,003  Genotoxic
0,871  0,003  UGT1A6 substrate
0,837  0,003  UGT1A9 substrate
0,833  0,003  CTGF expression inhibitor
0,830  0,004  Aldehyde oxidase inhibitor
0,809  0,010  Caspase 9 stimulant
0,770  0,004  Antimutagenic
0,759  0,013  Antineoplastic (breast cancer)
0,743  0,014  Antineoplastic (lung cancer)
0,729  0,003  UGT1A3 substrate
0,719  0,004  UGT1A1 substrate
0,701  0,006  NOS2 expression inhibitor
0,721  0,027  Apoptosis agonist
0,690  0,004  UGT1A4 substrate
0,684  0,002  Cystathionine beta-synthase inhibitor
0,680  0,006  Caspase 3 stimulant
0,685  0,015  Antineoplastic (colorectal cancer)
0,679  0,009  CYP1A2 substrate
0,673  0,008  Antineoplastic (cervical cancer)
0,678  0,015  Antineoplastic (colon cancer)
0,659  0,002  UGT2B15 substrate
0,661  0,013  Prostate cancer treatment
0,651  0,004  Topoisomerase II inhibitor
0,643  0,004  Sulfotransferase substrate
0,633  0,015  Carcinogenic
0,636  0,020  TNF expression inhibitor
0,626  0,021  Antileukemic
0,616  0,013  CYP2C19 substrate
0,608  0,008  Ulceration
0,607  0,012  Antineoplastic (melanoma)
0,623  0,028  Transcription factor NF kappa B inhibitor
0,609  0,022  15-Lipoxygenase inhibitor
0,600  0,015  Antineoplastic (ovarian cancer)
0,590  0,014  12-Lipoxygenase inhibitor
0,583  0,015  Mutagenic
0,575  0,010  Antineoplastic (glioma)
0,568  0,008  UDP-glucuronosyltransferase substrate
0,566  0,012  Antineoplastic (non-small cell lung cancer)
0,557  0,005  Antiseptic
0,555  0,006  Carcinogenic, group 3
0,562  0,014  AR expression inhibitor
0,552  0,008  Antineoplastic (glioblastoma multiforme)
0,559  0,018  Sensitization
0,532  0,003  SULT1A3 substrate
0,533  0,005  Antineoplastic (small cell lung cancer)
0,550  0,027  CYP2C9 substrate
0,538  0,017  Cytostatic
0,525  0,008  UGT2B4 substrate
0,535  0,020  Chemoprotective
0,545  0,034  CYP3A4 substrate
0,525  0,016  Antineoplastic (brain cancer)
0,518  0,018  Antioxidant
0,513  0,015  Free radical scavenger
0,511  0,014  Hypoxia-inducible factor 1 alpha inhibitor
0,498  0,004  Topoisomerase II alpha inhibitor
0,520  0,027  Antipruritic, allergic
0,501  0,009  Peroxidase inhibitor
0,512  0,025  Bone diseases treatment
0,504  0,020  Antiosteoporotic
0,488  0,005  NOS3 expression enhancer
0,509  0,026  Histamine release inhibitor
0,506  0,024  GABA C receptor rho-3 antagonist
0,490  0,016  Antipyretic
0,478  0,004  Neurotrophic factor enhancer
0,491  0,021  NOS3 expression inhibitor
0,490  0,020  Lipoxygenase inhibitor
0,466  0,002  SULT1A1 substrate
0,467  0,004  Estrogen receptor alpha antagonist
0,483  0,021  Chemopreventive
0,461  0,003  Keratolytic
0,460  0,005  UGT2B1 substrate
0,488  0,036  5 Hydroxytryptamine release inhibitor
0,468  0,017  DNA damaging
0,470  0,024  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,473  0,030  CYP2D6 substrate
0,446  0,006  Pneumotoxic
0,474  0,035  Teratogen
0,465  0,029  Cytotoxic
0,449  0,014  Pyruvate kinase inhibitor
0,463  0,029  FMO1 substrate
0,441  0,008  UGT2B7 substrate
0,453  0,021  CYP1A2 inhibitor
0,445  0,016  Antineoplastic (osteosarcoma)
0,438  0,009  Antineoplastic (squamous cell carcinoma)
0,428  0,004  Estrogen antagonist
0,500  0,081  Alpha-glucosidase inhibitor
0,433  0,014  Transcription factor STAT inhibitor
0,434  0,017  Antineoplastic (renal cancer)
0,439  0,025  Cardiovascular analeptic
0,439  0,026  Antineoplastic (multiple myeloma)
0,440  0,036  Antihypercholesterolemic
0,441  0,037  Embryotoxic
0,408  0,009  Amylase inhibitor
0,414  0,014  Antineoplastic (sarcoma)
0,415  0,016  Transcription factor STAT3 inhibitor
0,407  0,012  Skin whitener
0,439  0,044  CYP2C19 inhibitor
0,403  0,012  Melanin inhibitor
0,424  0,033  Antineoplastic (pancreatic cancer)
0,445  0,059  Antibacterial
0,392  0,005  Topoisomerase I inhibitor
0,383  0,004  Estrogen agonist
0,392  0,013  Antineoplastic (carcinoma)
0,381  0,004  Estrogen receptor beta antagonist
0,393  0,020  Antineoplastic (lymphocytic leukemia)
0,395  0,030  Proliferative diseases treatment
0,373  0,013  Tubulin antagonist
0,380  0,024  Antihypertriglyceridemic
0,382  0,026  Antineoplastic (liver cancer)
0,380  0,026  Antimitotic
0,361  0,009  DNA intercalator
0,359  0,007  Carcinogenic, group 2B
0,373  0,021  RNA-directed DNA polymerase inhibitor
0,351  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,378  0,034  Calcium channel activator
0,399  0,058  CYP2C9 inhibitor
0,346  0,008  Aldehyde dehydrogenase inhibitor
0,350  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,410  0,074  Calcium channel L-type activator
0,340  0,004  Postmenopausal disorders treatment
0,365  0,031  Amyloid beta aggregation inhibitor
0,367  0,033  Antineoplastic (lymphoma)
0,381  0,048  Respiratory analeptic
0,350  0,018  Antihypotensive
0,368  0,036  Radiosensitizer
0,338  0,007  Antifungal enhancer
0,337  0,007  Hexokinase inhibitor
0,349  0,024  Antineoplastic (bladder cancer)
0,352  0,036  FMO3 substrate
0,348  0,032  Nitric oxide antagonist
0,349  0,040  Antihypoxic
0,330  0,020  Contraceptive
0,315  0,007  Xanthine oxidase inhibitor
0,321  0,016  Lipid peroxidase inhibitor
0,358  0,058  ICAM1 expression inhibitor
0,354  0,055  5 Hydroxytryptamine release stimulant
0,306  0,009  Heat shock protein 90 antagonist
0,348  0,052  Radioprotector
0,347  0,053  Cardioprotectant
0,309  0,017  Monophenol monooxygenase inhibitor
0,347  0,057  Vasodilator, coronary
0,302  0,019  Interferon gamma antagonist
0,286  0,005  Beta tubulin antagonist
0,296  0,017  Protein kinase stimulant
0,326  0,048  Antineoplastic (endocrine cancer)
0,341  0,064  Antifungal
0,314  0,038  5 Hydroxytryptamine uptake stimulant
0,285  0,012  5-Lipoxygenase inhibitor
0,277  0,005  Creatine kinase inhibitor
0,315  0,045  Superoxide dismutase inhibitor
0,301  0,033  Tyrosine 3 hydroxylase inhibitor
0,282  0,018  Heat shock protein 90 alpha antagonist
0,290  0,029  VCAM1 expression inhibitor
0,291  0,031  P-glycoprotein inhibitor
0,301  0,041  Cyclic AMP phosphodiesterase inhibitor
0,269  0,009  UGT2B10 substrate
0,271  0,011  Endometrios treatment
0,263  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,273  0,015  UGT2B9 substrate
0,308  0,050  Hypoglycemic
0,263  0,005  CF transmembrane conductance regulator agonist
0,263  0,006  Coagulant
0,345  0,089  Immunosuppressant
0,265  0,011  Antihemorrhagic
0,257  0,005  Alpha tubulin antagonist
0,261  0,010  VEGF expression inhibitor
0,285  0,034  Hepatoprotectant
0,316  0,066  Analeptic
0,255  0,006  Antirickettsial
0,266  0,018  NADPH oxidase inhibitor
0,265  0,017  Glutathione S-transferase substrate
0,262  0,015  Alkylator
0,284  0,039  Abortion inducer
0,312  0,069  Sodium/bile acid cotransporter inhibitor
0,294  0,052  GST M1-1 substrate
0,289  0,048  DNA synthesis inhibitor
0,265  0,024  Nitric-oxide synthase stimulant
0,257  0,019  Antineoplastic (bone cancer)
0,270  0,034  Dual specificity phosphatase inhibitor
0,293  0,058  Flavin-containing monooxygenase substrate
0,282  0,048  Antiparasitic
0,254  0,020  MAO A inhibitor
0,246  0,013  Carbonic anhydrase XV inhibitor
0,264  0,031  CYP2B6 inhibitor
0,233  0,004  DOPA decarboxylase inhibitor
0,229  0,005  Prolactin inhibitor
0,239  0,017  Gout treatment
0,224  0,004  Estrogen receptor beta agonist
0,298  0,079  Antimycobacterial
0,303  0,084  Apoptosis antagonist
0,231  0,013  Toll-Like receptor 2 antagonist
0,318  0,101  GST A substrate
0,225  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,229  0,012  Carbonic anhydrase III inhibitor
0,275  0,059  Cardiodepressant
0,311  0,097  Prostaglandin dehydrogenase inhibitor
0,219  0,005  SULT1E1 substrate
0,216  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,254  0,043  Antialcoholic
0,247  0,036  Antipruritic, non-allergic
0,284  0,073  Antituberculosic
0,273  0,063  Interleukin agonist
0,304  0,097  Antiprotozoal (Plasmodium)
0,267  0,061  Gastrin inhibitor
0,222  0,017  Interleukin 4 antagonist
0,233  0,030  Skin irritative effect
0,234  0,032  MAO inhibitor
0,241  0,040  Insulin sensitizer
0,211  0,011  Beta glucuronidase inhibitor
0,293  0,096  Cholesterol antagonist
0,208  0,011  Photosensitizer
0,201  0,005  Antiprotozoal activity enhancer
0,242  0,048  Antihelmintic
0,204  0,011  HIV-1 integrase (Overall Integration) inhibitor
0,203  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,221  0,028  M18 aspartyl aminopeptidase inhibitor
0,340  0,147  Antineoplastic (solid tumors)
0,225  0,035  LDLR expression enhancer
0,292  0,101  Vasodilator, peripheral
0,216  0,026  Antiprotozoal (Coccidial)
0,201  0,013  Carbonic anhydrase VI inhibitor
0,200  0,014  Contraceptive female
0,306  0,120  Antiprotozoal
0,188  0,003  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,189  0,004  Topoisomerase II beta inhibitor
0,209  0,025  Cholesterol synthesis inhibitor
0,205  0,020  Antineoplastic antibiotic
0,195  0,011  Antineoplastic (uterine cancer)
0,188  0,004  SULT1A2 substrate
0,258  0,075  Aryl hydrocarbon receptor agonist
0,197  0,014  Antispirochetal
0,187  0,005  UGT2B11 substrate
0,209  0,030  Phobic disorders treatment
0,209  0,030  Carcinogenic, group 1
0,196  0,017  Antihelmintic (Trematoda)
0,206  0,028  Arachidonic acid antagonist
0,222  0,044  Eye irritation, high
0,186  0,009  Macrophage migration inhibitory factor inhibitor
0,214  0,038  Prostate disorders treatment
0,192  0,017  Adenylate cyclase stimulant
0,244  0,072  Vasodilator
0,346  0,175  Antiinflammatory
0,180  0,010  Aromatase inhibitor
0,233  0,063  Antineoplastic enhancer
0,173  0,005  Estrogen receptor alpha agonist
0,286  0,118  Antineoplastic (non-Hodgkin's lymphoma)
0,183  0,015  TRPA1 agonist
0,216  0,048  Mcl-1 antagonist
0,210  0,044  Acaricide
0,175  0,009  Ca2+-transporting ATPase inhibitor
0,190  0,025  Farnesoid X receptor antagonist
0,206  0,044  Protein-tyrosine phosphatase inhibitor
0,175  0,014  Heat shock protein 70 antagonist
0,243  0,082  5 Hydroxytryptamine 1E antagonist
0,169  0,010  Anabolic
0,205  0,048  Antihelmintic (Nematodes)
0,187  0,034  Psychosexual dysfunction treatment
0,157  0,004  Heat shock protein 90 beta antagonist
0,190  0,037  Alkaline phosphatase inhibitor
0,232  0,080  Antiamyloidogenic
0,176  0,026  Microtubule formation inhibitor
0,221  0,075  Peptidyltransferase inhibitor
0,200  0,055  Prostatic (benign) hyperplasia treatment
0,184  0,039  GABA C receptor rho-2 antagonist
0,196  0,052  Succinate dehydrogenase inhibitor
0,252  0,108  Hepatic disorders treatment
0,160  0,017  Actinic keratosis treatment
0,147  0,007  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,151  0,012  CDC25A inhibitor
0,157  0,019  Transcription factor STAT6 inhibitor
0,160  0,023  DNA repair enzyme inhibitor
0,180  0,043  Cyclooxygenase 1 inhibitor
0,170  0,033  Cyclooxygenase 3 inhibitor
0,186  0,050  ATPase inhibitor
0,172  0,036  Antihyperlipoproteinemic
0,231  0,100  Spasmolytic
0,159  0,029  Choleretic
0,150  0,020  Alcohol dehydrogenase inhibitor
0,150  0,022  Carcinogenic, group 2A
0,179  0,051  Antidote
0,139  0,012  Antifungal (Aspergillus)
0,200  0,074  Antiviral (Influenza)
0,236  0,112  Streptokinase A inhibitor
0,144  0,020  Histidine decarboxylase inhibitor
0,130  0,007  Estrogen-related receptor beta agonist
0,182  0,059  Phospholipase C inhibitor
0,170  0,049  Mannose-6-phosphate isomerase inhibitor
0,156  0,035  MAO B inhibitor
0,195  0,075  Non-steroidal antiinflammatory agent
0,196  0,076  Histone acetyltransferase inhibitor
0,149  0,029  Antiviral (Influenza B)
0,139  0,019  Antiviral (Trachoma)
0,126  0,010  CDC25B inhibitor
0,122  0,006  Fatty acid synthase inhibitor
0,149  0,035  Papain-like protease (SARS coronavirus) inhibitor
0,164  0,050  Bone formation stimulant
0,139  0,025  Androgen antagonist
0,244  0,131  Antithrombotic
0,230  0,117  Insulysin inhibitor
0,150  0,038  Gastritis treatment
0,138  0,028  Uric acid excretion stimulant
0,145  0,035  NAT2 substrate
0,239  0,131  Thyroid hormone antagonist
0,111  0,003  ATP citrate lysase inhibitor
0,123  0,016  Thioredoxin reductase inhibitor
0,143  0,038  Chelator
0,146  0,042  Vanilloid 1 agonist
0,124  0,020  Contraceptive male
0,129  0,025  Thioredoxin inhibitor
0,170  0,067  Catenin beta inhibitor
0,177  0,075  Dual specificity phosphatase 3 inhibitor
0,140  0,039  Mucolytic
0,106  0,005  Transcription factor RelA inhibitor
0,107  0,006  SULT2A1 substrate
0,136  0,035  Antifungal (Pneumocystis)
0,147  0,047  Protein-tyrosine phosphatase 1B inhibitor
0,166  0,066  Antiviral (Herpes)
0,105  0,005  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,133  0,034  Urease inhibitor
0,153  0,054  Antifungal (Cryptococcus)
0,102  0,004  Dopamine D5 agonist
0,209  0,112  Antiprotozoal (Trypanosoma)
0,194  0,098  Angiogenesis stimulant
0,144  0,049  Adenylate cyclase inhibitor
0,164  0,069  Uterine stimulant
0,136  0,041  Expectorant
0,112  0,018  D-Ala-D-Ala ligase inhibitor
0,111  0,017  Narcotic antagonist
0,227  0,133  Thyroid hormone beta antagonist
0,149  0,056  Acetylcholinesterase inhibitor
0,127  0,034  Breast cancer-resistant protein inhibitor
0,099  0,006  Postcoital contraceptive
0,159  0,067  Antiviral (Influenza A)
0,144  0,053  DNA polymerase I inhibitor
0,195  0,103  Antiprotozoal (Leishmania)
0,130  0,039  Multidrug resistance-associated protein 1 inhibitor
0,115  0,024  Bile acid receptor antagonist
0,147  0,059  Pregnane X receptor agonist
0,122  0,034  Arylamine N-Acetyltransferase substrate
0,099  0,011  Glutamate (mGluR7) antagonist
0,102  0,015  Xanthine dehydrogenase inhibitor
0,115  0,028  Telomerase inhibitor
0,149  0,063  MAP kinase kinase 4 inhibitor
0,168  0,083  Lipocortins synthesis antagonist
0,099  0,014  MAP kinase kinase 7 inhibitor
0,162  0,078  Sigma receptor agonist
0,161  0,077  Neurotensin receptor agonist
0,125  0,041  Electron transport complex I inhibitor
0,125  0,042  Antineoplastic, alkylator
0,100  0,018  Anticholelithogenic
0,113  0,032  Carbonic anhydrase XIII inhibitor
0,134  0,054  Growth stimulant
0,093  0,015  Antimycoplasmal
0,116  0,038  NMDA receptor antagonist
0,125  0,047  GABA C receptor antagonist
0,173  0,097  Psychostimulant
0,112  0,037  ABCA1 expression enhancer
0,197  0,122  Immunostimulant
0,150  0,077  Aldose reductase substrate
0,109  0,035  Ornithine decarboxylase inhibitor
0,220  0,147  CYP3A4 inhibitor
0,147  0,075  Antidiarrheal
0,120  0,049  AMP-activated protein kinase stimulant
0,097  0,026  HIV-1 integrase inhibitor
0,138  0,068  Antiacne
0,128  0,058  Sphingosine 1-phosphate receptor 4 antagonist
0,160  0,092  Antineoplastic (gastric cancer)
0,108  0,040  Paget's disease treatment
0,115  0,047  Chronic obstructive bronchitis treatment
0,094  0,029  Leukotriene synthesis inhibitor
0,095  0,031  GABA aminotransferase inhibitor
0,079  0,016  Heme oxygenase stimulant
0,174  0,115  Antiviral (Ebola)
0,250  0,190  MAP kinase kinase 6 inhibitor
0,082  0,023  Androgen agonist
0,113  0,054  Antiprotozoal (Toxoplasma)
0,123  0,065  Antiprotozoal (Amoeba)
0,080  0,022  Transcription factor AP-1 inhibitor
0,129  0,074  Cocaine dependence treatment
0,120  0,065  Alcohol dehydrogenase substrate
0,059  0,004  Estrogen-related receptor beta antagonist
0,191  0,136  Antiviral (West Nile virus)
0,078  0,024  Aldose reductase inhibitor
0,074  0,021  Calcium channel P-type blocker
0,067  0,014  Adenylate cyclase 1 inhibitor
0,127  0,075  Toll-Like receptor antagonist
0,153  0,101  DNA methyltransferase I inhibitor
0,087  0,038  Glutamate decarboxylase inhibitor
0,089  0,042  Na+ K+ transporting ATPase inhibitor
0,100  0,053  Antifungal (Candida)
0,114  0,069  Menstruation disorders treatment
0,078  0,034  Dopamine D1 antagonist
0,150  0,106  Platelet adhesion inhibitor
0,282  0,239  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,057  0,014  Guanylate cyclase inhibitor
0,073  0,031  Antihemophilic
0,064  0,023  DNA helicase inhibitor
0,129  0,089  Cyclooxygenase inhibitor
0,162  0,123  Antiparkinsonian, rigidity relieving
0,111  0,072  Antitussive
0,077  0,039  Carbonic anhydrase VA inhibitor
0,150  0,113  Anesthetic general
0,152  0,115  DNA methylase inhibitor
0,049  0,012  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,085  0,049  CC chemokine 5 receptor agonist
0,052  0,015  DNA gyrase subunit A inhibitor
0,069  0,033  TRPA1 antagonist
0,043  0,008  Estrone sulfatase inhibitor
0,071  0,036  5 Hydroxytryptamine 2A agonist
0,046  0,012  Purinergic P2Y2 antagonist
0,080  0,046  Antibiotic
0,091  0,058  Triose-phosphate isomerase inhibitor
0,132  0,098  Phospholipase A2 inhibitor
0,118  0,085  Antibacterial (Helicobacter pylori)
0,080  0,047  Porphobilinogen synthase inhibitor
0,078  0,045  Cathepsin G inhibitor
0,131  0,099  Sphingosine 1-phosphate receptor 5 antagonist
0,041  0,010  Protein 30S ribosomal subunit inhibitor
0,051  0,019  NMDA receptor subunit 3A antagonist
0,078  0,047  NAT1 substrate
0,065  0,034  Cyclin D1 inhibitor
0,071  0,042  Carbonic anhydrase V inhibitor
0,097  0,067  GABA C receptor rho-1 antagonist
0,035  0,007  Dopamine D1 agonist
0,115  0,087  Retinoprotector
0,056  0,028  Alpha 1L adrenoreceptor antagonist
0,076  0,049  Glutamate dehydrogenase inhibitor
0,120  0,094  Hair growth stimulant
0,061  0,035  Carbonic anhydrase VB inhibitor
0,074  0,048  Glycine receptor agonist
0,067  0,041  Protease 3C (Human rhinovirus) inhibitor
0,076  0,050  GABA B receptor agonist
0,050  0,025  NMDA receptor subunit 3B antagonist
0,060  0,035  Alcohol oxidase inhibitor
0,090  0,065  Protein kinase C zeta inhibitor
0,113  0,088  Cyclooxygenase 2 inhibitor
0,039  0,015  Nucleoside transporters inhibitor
0,229  0,205  DNA directed DNA polymerase inhibitor
0,136  0,113  Antipruritic
0,026  0,003  Antibiotic Tetracycline-like
0,050  0,029  Aldosterone antagonist
0,062  0,042  Prolactin release inhibitor
0,037  0,017  Catechol O-methyltransferase inhibitor
0,042  0,022  5-Alpha-reductase inhibitor
0,085  0,065  Tocolytic
0,054  0,034  NMDA 2A receptor antagonist
0,062  0,043  NMDA 2C receptor antagonist
0,051  0,033  CD45 antagonist
0,091  0,072  UDP-glucose 4-epimerase inhibitor
0,051  0,033  Squalene epoxidase inhibitor
0,024  0,006  Antibiotic Anthracycline-like
0,225  0,207  DNA polymerase beta inhibitor
0,028  0,012  Vanilloid 2 agonist
0,083  0,067  Granulocyte macrophage colony stimulating factor agonist
0,041  0,025  Cholesterol absorption inhibitor
0,096  0,080  Antihelmintic (Fasciola)
0,042  0,027  Cathepsin L2 inhibitor
0,028  0,013  Sodium/glucose cotransporter 1 inhibitor
0,085  0,070  Antischistosomal
0,083  0,069  Antidote, mercury
0,056  0,041  Pregnane X receptor antagonist
0,029  0,014  Thyroid hormone agonist
0,037  0,022  Retinoid X alpha receptor agonist
0,084  0,070  ATPase (Vacuolar H+) inhibitor
0,089  0,075  Interleukin 12 antagonist
0,083  0,069  NADH dehydrogenase inhibitor
0,113  0,100  Antiprotozoal (Trichomonas)
0,079  0,066  Antineoplastic alkaloid
0,046  0,033  Carbonic anhydrase VII inhibitor
0,062  0,050  Dopamine agonist
0,034  0,022  Estrogen-related receptor alpha antagonist
0,081  0,071  Interleukin 5 antagonist
0,038  0,028  Alpha 1d adrenoreceptor agonist
0,062  0,053  Uterine relaxant
0,056  0,047  Lipocortins synthesis agonist
0,026  0,018  Sodium/glucose cotransporter 2 inhibitor
0,102  0,093  Interleukin 8 antagonist
0,026  0,017  Sodium/glucose cotransporter inhibitor
0,034  0,026  Retinoid X receptor agonist
0,079  0,072  Vanilloid agonist
0,074  0,067  Glycine receptor antagonist
0,052  0,045  Dihydroorotate oxidase inhibitor
0,081  0,074  Potassium channel (Ca-activated) activator
0,092  0,086  5 Hydroxytryptamine 3A agonist
0,036  0,030  Urate transporter 1 inhibitor
0,057  0,051  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,077  0,072  Myeloperoxidase inhibitor
0,063  0,057  Glutamate (mGluR6) antagonist
0,036  0,030  Glucose-6-phosphate dehydrogenase inhibitor
0,038  0,033  Liver X receptor alpha agonist
0,055  0,050  Antidote, heavy metal
0,088  0,084  Mediator release inhibitor
0,057  0,054  Purinergic P2X2 antagonist
0,077  0,074  GST P1-1 substrate
0,031  0,027  Glutamate (mGluR3) agonist
0,130  0,127  Movement disorders treatment
0,130  0,127  Tumour necrosis factor antagonist
0,014  0,012  NMDA receptor phencyclidine site antagonist
0,058  0,057  Aryl hydrocarbon receptor antagonist
0,049  0,047  Leukotriene B4 antagonist
0,118  0,117  Hemostatic
0,038  0,038  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor

